Study finds patients with long COVID exhibit complement dysregulation with signs of thromboinflammation Post author: Post published:January 23, 2024 Post category:uncategorized Researchers explore inflammatory signatures restricted to patients with active post-acute COVID-19 sequelae. You Might Also Like Top-five pharmaceutical company expands partnership with Aptamer for multi-target Optimer® development program November 4, 2025 Natural diversity boosts mental wellbeing, research shows April 16, 2024 Fine particulate matter linked to higher eczema risk November 20, 2024
Top-five pharmaceutical company expands partnership with Aptamer for multi-target Optimer® development program November 4, 2025